Healthcare -
Biotechnology - NASDAQ - US
$ 0.9027
-7.34 %
$ 46.9 M
Market Cap
-0.76
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
PMV Pharmaceuticals, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 85.4 M |
| Operating Income | -85.4 M |
| Other Expenses | -26.7 M |
| Net Income | -58.7 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||||
| Cost Of Revenue | 0 | 1.3 | 0.7 | 1.3 | 0.3 | 0.4 | 0.3 |
| Gross Profit | 0 | (1.3) | (0.7) | (1.3) | (0.3) | (0.4) | (0.3) |
| OPERATING INCOME | |||||||
| Operating Expenses | 85.4 | 80.1 | 77.0 | 58.3 | 34.9 | 26.6 | 18.9 |
| Selling, General and Administrative Expenses | 26.9 | 24.2 | 25.1 | 21.8 | 11.0 | 5.9 | 5.0 |
| Research and Development Expenses | 57.4 | 54.6 | 52.0 | 36.5 | 23.9 | 20.8 | 13.9 |
| Operating Income | (85.4) | (80.1) | (77.0) | (58.3) | (34.9) | (26.6) | (18.9) |
| PRE-TAX INCOME | |||||||
| Interest Income Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | 10.6 | 11.2 | 3.7 | 0.5 | 0.5 | 1.3 | 1.4 |
| Pre-Tax Income | (74.8) | (69.0) | (73.3) | (57.8) | (34.4) | (25.3) | (17.5) |
| NET INCOME | |||||||
| Tax Provision | (16.1) | 2 K | 9 K | 23 K | 6 K | 8 K | 3 K |
| Net Income | (58.7) | (69.0) | (73.3) | (57.8) | (34.4) | (25.4) | (17.5) |
| EPS | 1.14 | 1.44 | 1.61 | 1.28 | 2.4 | 0.59 | 0.56 |